Year 2018 / Volume 110 / Number 5
Original
Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information

274-284

DOI: 10.17235/reed.2018.5331/2017

Carmen Martín Fernández, Carlos Maroto Martín, Luis Fernández Salazar,

Abstract
Background and aims: patients need information for shared decision making. The aims of the study were to ascertain how patients with inflammatory bowel disease (IBD) felt about the information available and the way that their doctors informed them. In addition, how patients used the internet and factors that predicted a positive information evaluation were also assessed. Method: a 39-item survey was designed that was distributed via the internet, principally using a Spanish Facebook site. Results: four hundred and twenty completed surveys were received. Patients rated the information available with a mean of 8 points (maximum of 10) and 71% felt that their doctor informed them well or very well. Various deficiencies were found such as little information available at the time of diagnosis (58%); doubts after seeing the specialist (70%); insufficient information about IBD complications, disease course and dietary aspects; and a lack of appropriate internet webpage recommendations from specialists or pharmacists. Patients ranked the internet fourth as an information source, followed by their specialist, patient associations and other patients. Independent predictive factors of feeling well informed (≥ 8) included age, OR 1.539 (CI 1.047-2.261), p = 0.028; education, OR 1.544 (CI 1.110-2.147), p = 0,010; IBD evolution time, OR 1.267 (CI 1.003-1,601), p = 0.047; and good or very good information from the specialist, OR 3.262 (CI 2.425-4.388), p < 0.001. Conclusions: patients generally felt that they were well informed. However, there were aspects that needed improvement, such as information for younger patients or a lower education level, the information provided at diagnosis, information about specific or insufficiently covered IBD aspects and suggestions from doctors about high quality websites.
Share Button
New comment
Comments
No comments for this article
References
1. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflammatory bowel diseases. 2011;17(2):590-8.
DOI: 10.1002/ibd.21363
2. Becker HM, Grigat D, Ghosh S, Kaplan GG, Dieleman L, Wine E, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian journal of gastroenterology & hepatology. 2015;29(2):77-84.
DOI: 10.1155/2015/815820
3. Catalan-Serra I, Huguet-Malaves JM, Minguez M, Torrella E, Paredes JM, Vazquez N, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterologia y hepatologia. 2015;38(6):355-63.
DOI: 10.1016/j.gastrohep.2014.09.003
4. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal (Clinical research ed). 1986;292(6516):344.
DOI: 10.1136/bmj.292.6516.344
5. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003;25(4):277-83.
DOI: 10.1016/S0163-8343(03)00043-4
6. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995;7(9):853-8.
7. Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score. European journal of gastroenterology & hepatology. 2014;26(1):1-5.
DOI: 10.1097/MEG.0b013e328365d21a
8. Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflammatory bowel diseases. 2015;21(3):615-22.
DOI: 10.1097/MIB.0000000000000304
9. Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Journal of clinical gastroenterology. 1993;17(1):21-4.
DOI: 10.1097/00004836-199307000-00007
10. Eaden JA, Abrams K, Mayberry JF. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. The American journal of gastroenterology. 1999;94(12):3560-6.
DOI: 10.1111/j.1572-0241.1999.01536.x
11. Keegan D, McDermott E, Byrne K, Moloney D, Doherty GA, Mulcahy HE. Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2013;48(2):183-8.
DOI: 10.3109/00365521.2012.744090
12. Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, et al. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? PloS one. 2016;11(3):e0150620.
DOI: 10.1371/journal.pone.0150620
13. Wong S, Walker JR, Carr R, Graff LA, Clara I, Promislow S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012;26(8):525-31.
DOI: 10.1155/2012/735386
14. Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, et al. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2014;49(6):662-73.
DOI: 10.3109/00365521.2014.896408
15. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary pharmacology & therapeutics. 2012;36(1):57-63.
DOI: 10.1111/j.1365-2036.2012.05130.x
16. Berroa E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA. Are Worries and Concerns Information Side Effects? Inflammatory bowel diseases. 2015;21(9):E22.
DOI: 10.1097/MIB.0000000000000539
17. Panes J, de Lacy AM, Sans M, Soriano A, Pique JM. [Frequent Internet use among Catalan patients with inflammatory bowel disease]. Gastroenterologia y hepatologia. 2002;25(5):306-9.
18. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. European journal of gastroenterology & hepatology. 2009;21(9):1036-41.
DOI: 10.1097/MEG.0b013e328321b112
19. Nguyen DL, Rasheed S, Parekh NK. Patterns of Internet use by gastroenterologists in the management and education of patients with inflammatory bowel disease. Southern medical journal. 2014;107(5):320-3.
DOI: 10.1097/SMJ.0000000000000107
20. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, et al. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016;22(11):2678-87.
DOI: 10.1097/MIB.0000000000000951
21. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59(12):1652-61.
DOI: 10.1136/gut.2010.220160
22. Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's & colitis. 2016;10(9):1103-21.
DOI: 10.1093/ecco-jcc/jjw059
1. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflammatory bowel diseases. 2011;17(2):590-8.
DOI: 10.1002/ibd.21363
2. Becker HM, Grigat D, Ghosh S, Kaplan GG, Dieleman L, Wine E, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian journal of gastroenterology & hepatology. 2015;29(2):77-84.
DOI: 10.1155/2015/815820
3. Catalan-Serra I, Huguet-Malaves JM, Minguez M, Torrella E, Paredes JM, Vazquez N, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterologia y hepatologia. 2015;38(6):355-63.
DOI: 10.1016/j.gastrohep.2014.09.003
4. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal (Clinical research ed). 1986;292(6516):344.
DOI: 10.1136/bmj.292.6516.344
5. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003;25(4):277-83.
DOI: 10.1016/S0163-8343(03)00043-4
6. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995;7(9):853-8.
7. Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score. European journal of gastroenterology & hepatology. 2014;26(1):1-5.
DOI: 10.1097/MEG.0b013e328365d21a
8. Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflammatory bowel diseases. 2015;21(3):615-22.
DOI: 10.1097/MIB.0000000000000304
9. Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Journal of clinical gastroenterology. 1993;17(1):21-4.
DOI: 10.1097/00004836-199307000-00007
10. Eaden JA, Abrams K, Mayberry JF. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. The American journal of gastroenterology. 1999;94(12):3560-6.
DOI: 10.1111/j.1572-0241.1999.01536.x
11. Keegan D, McDermott E, Byrne K, Moloney D, Doherty GA, Mulcahy HE. Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2013;48(2):183-8.
DOI: 10.3109/00365521.2012.744090
12. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2004;96(3):174-84.
DOI: 10.4321/S1130-01082004000300003
13. Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, et al. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? PloS one. 2016;11(3):e0150620.
DOI: 10.1371/journal.pone.0150620
14. Wong S, Walker JR, Carr R, Graff LA, Clara I, Promislow S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012;26(8):525-31.
DOI: 10.1155/2012/735386
15. Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, et al. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2014;49(6):662-73.
DOI: 10.3109/00365521.2014.896408
16. de Castro ML, Sanroman L, Martin A, Figueira M, Martinez N, Hernandez V, et al. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(8):542-51.
17. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary pharmacology & therapeutics. 2012;36(1):57-63.
DOI: 10.1111/j.1365-2036.2012.05130.x
18. Berroa E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA. Are Worries and Concerns Information Side Effects? Inflammatory bowel diseases. 2015;21(9):E22.
DOI: 10.1097/MIB.0000000000000539
19. Panes J, de Lacy AM, Sans M, Soriano A, Pique JM. [Frequent Internet use among Catalan patients with inflammatory bowel disease]. Gastroenterologia y hepatologia. 2002;25(5):306-9.
20. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. European journal of gastroenterology & hepatology. 2009;21(9):1036-41.
DOI: 10.1097/MEG.0b013e328321b112
21. Nguyen DL, Rasheed S, Parekh NK. Patterns of Internet use by gastroenterologists in the management and education of patients with inflammatory bowel disease. Southern medical journal. 2014;107(5):320-3.
DOI: 10.1097/SMJ.0000000000000107
22. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, et al. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016;22(11):2678-87.
DOI: 10.1097/MIB.0000000000000951
23. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59(12):1652-61.
DOI: 10.1136/gut.2010.220160
24. Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's & colitis. 2016;10(9):1103-21.
DOI: 10.1093/ecco-jcc/jjw059
1. Marin-Jimenez I, Gobbo Montoya M, Panadero A, Canas M, Modino Y, Romero de Santos C, et al. Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project. Inflammatory bowel diseases. 2017;23(9):1492-8.
DOI: 10.1097/MIB.0000000000001205
2. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflammatory bowel diseases. 2011;17(2):590-8.
DOI: 10.1002/ibd.21363
3. Becker HM, Grigat D, Ghosh S, Kaplan GG, Dieleman L, Wine E, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian journal of gastroenterology & hepatology. 2015;29(2):77-84.
DOI: 10.1155/2015/815820
4. Catalan-Serra I, Huguet-Malaves JM, Minguez M, Torrella E, Paredes JM, Vazquez N, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterologia y hepatologia. 2015;38(6):355-63.
DOI: 10.1016/j.gastrohep.2014.09.003
5. Stjernman H, Tysk C, Almer S, Strom M, Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scandinavian journal of gastroenterology. 2010;45(6):696-706.
DOI: 10.3109/00365521003734141
6. Jelsness-Jorgensen LP, Moum B, Bernklev T. Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterology research and practice. 2011;2011:492034.
DOI: 10.1155/2011/492034
7. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal (Clinical research ed). 1986;292(6516):344.
DOI: 10.1136/bmj.292.6516.344
8. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003;25(4):277-83.
DOI: 10.1016/S0163-8343(03)00043-4
9. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995;7(9):853-8.
10. Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score. European journal of gastroenterology & hepatology. 2014;26(1):1-5.
DOI: 10.1097/MEG.0b013e328365d21a
11. Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflammatory bowel diseases. 2015;21(3):615-22.
DOI: 10.1097/MIB.0000000000000304
12. Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Journal of clinical gastroenterology. 1993;17(1):21-4.
DOI: 10.1097/00004836-199307000-00007
13. Eaden JA, Abrams K, Mayberry JF. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. The American journal of gastroenterology. 1999;94(12):3560-6.
DOI: 10.1111/j.1572-0241.1999.01536.x
14. Keegan D, McDermott E, Byrne K, Moloney D, Doherty GA, Mulcahy HE. Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2013;48(2):183-8.
DOI: 10.3109/00365521.2012.744090
15. Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2002;11(8):775-81.
DOI: 10.1023/A:1020841601110
16. Berroa de la Rosa E, Mora Cuadrado N, Fernandez Salazar L. The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(3):196-201.
DOI: 10.17235/reed.2017.4621/2016
17. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2004;96(3):174-84.
DOI: 10.4321/S1130-01082004000300003
18. Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, et al. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? PloS one. 2016;11(3):e0150620.
DOI: 10.1371/journal.pone.0150620
19. Wong S, Walker JR, Carr R, Graff LA, Clara I, Promislow S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012;26(8):525-31.
DOI: 10.1155/2012/735386
20. Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, et al. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2014;49(6):662-73.
DOI: 10.3109/00365521.2014.896408
21. de Castro ML, Sanroman L, Martin A, Figueira M, Martinez N, Hernandez V, et al. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(8):542-51.
22. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary pharmacology & therapeutics. 2012;36(1):57-63.
DOI: 10.1111/j.1365-2036.2012.05130.x
23. Berroa E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA. Are Worries and Concerns Information Side Effects? Inflammatory bowel diseases. 2015;21(9):E22.
DOI: 10.1097/MIB.0000000000000539
24. Panes J, de Lacy AM, Sans M, Soriano A, Pique JM. [Frequent Internet use among Catalan patients with inflammatory bowel disease]. Gastroenterologia y hepatologia. 2002;25(5):306-9.
25. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. European journal of gastroenterology & hepatology. 2009;21(9):1036-41.
DOI: 10.1097/MEG.0b013e328321b112
26. Nguyen DL, Rasheed S, Parekh NK. Patterns of Internet use by gastroenterologists in the management and education of patients with inflammatory bowel disease. Southern medical journal. 2014;107(5):320-3.
DOI: 10.1097/SMJ.0000000000000107
27. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, et al. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016;22(11):2678-87.
DOI: 10.1097/MIB.0000000000000951
28. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59(12):1652-61.
DOI: 10.1136/gut.2010.220160
29. Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's & colitis. 2016;10(9):1103-21.
DOI: 10.1093/ecco-jcc/jjw059
1. Marin-Jimenez I, Gobbo Montoya M, Panadero A, Canas M, Modino Y, Romero de Santos C, et al. Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project. Inflammatory bowel diseases. 2017;23(9):1492-8.
DOI: 10.1097/MIB.0000000000001205
2. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflammatory bowel diseases. 2011;17(2):590-8.
DOI: 10.1002/ibd.21363
3. Becker HM, Grigat D, Ghosh S, Kaplan GG, Dieleman L, Wine E, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian journal of gastroenterology & hepatology. 2015;29(2):77-84.
DOI: 10.1155/2015/815820
4. Catalan-Serra I, Huguet-Malaves JM, Minguez M, Torrella E, Paredes JM, Vazquez N, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterologia y hepatologia. 2015;38(6):355-63.
DOI: 10.1016/j.gastrohep.2014.09.003
5. Stjernman H, Tysk C, Almer S, Strom M, Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scandinavian journal of gastroenterology. 2010;45(6):696-706.
DOI: 10.3109/00365521003734141
6. Jelsness-Jorgensen LP, Moum B, Bernklev T. Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterology research and practice. 2011;2011:492034.
DOI: 10.1155/2011/492034
7. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal (Clinical research ed). 1986;292(6516):344.
DOI: 10.1136/bmj.292.6516.344
8. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003;25(4):277-83.
DOI: 10.1016/S0163-8343(03)00043-4
9. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995;7(9):853-8.
10. Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score. European journal of gastroenterology & hepatology. 2014;26(1):1-5.
DOI: 10.1097/MEG.0b013e328365d21a
11. Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflammatory bowel diseases. 2015;21(3):615-22.
DOI: 10.1097/MIB.0000000000000304
12. Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Journal of clinical gastroenterology. 1993;17(1):21-4.
DOI: 10.1097/00004836-199307000-00007
13. Eaden JA, Abrams K, Mayberry JF. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. The American journal of gastroenterology. 1999;94(12):3560-6.
DOI: 10.1111/j.1572-0241.1999.01536.x
14. Keegan D, McDermott E, Byrne K, Moloney D, Doherty GA, Mulcahy HE. Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2013;48(2):183-8.
DOI: 10.3109/00365521.2012.744090
15. Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2002;11(8):775-81.
DOI: 10.1023/A:1020841601110
16. Berroa de la Rosa E, Mora Cuadrado N, Fernandez Salazar L. The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(3):196-201.
DOI: 10.17235/reed.2017.4621/2016
17. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2004;96(3):174-84.
DOI: 10.4321/S1130-01082004000300003
18. Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, et al. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? PloS one. 2016;11(3):e0150620.
DOI: 10.1371/journal.pone.0150620
19. Wong S, Walker JR, Carr R, Graff LA, Clara I, Promislow S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012;26(8):525-31.
DOI: 10.1155/2012/735386
20. Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, et al. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2014;49(6):662-73.
DOI: 10.3109/00365521.2014.896408
21. de Castro ML, Sanroman L, Martin A, Figueira M, Martinez N, Hernandez V, et al. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(8):542-51.
22. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary pharmacology & therapeutics. 2012;36(1):57-63.
DOI: 10.1111/j.1365-2036.2012.05130.x
23. Berroa E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA. Are Worries and Concerns Information Side Effects? Inflammatory bowel diseases. 2015;21(9):E22.
DOI: 10.1097/MIB.0000000000000539
24. Panes J, de Lacy AM, Sans M, Soriano A, Pique JM. [Frequent Internet use among Catalan patients with inflammatory bowel disease]. Gastroenterologia y hepatologia. 2002;25(5):306-9.
25. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. European journal of gastroenterology & hepatology. 2009;21(9):1036-41.
DOI: 10.1097/MEG.0b013e328321b112
26. Nguyen DL, Rasheed S, Parekh NK. Patterns of Internet use by gastroenterologists in the management and education of patients with inflammatory bowel disease. Southern medical journal. 2014;107(5):320-3.
DOI: 10.1097/SMJ.0000000000000107
27. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, et al. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016;22(11):2678-87.
DOI: 10.1097/MIB.0000000000000951
28. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59(12):1652-61.
DOI: 10.1136/gut.2010.220160
29. Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's & colitis. 2016;10(9):1103-21.
DOI: 10.1093/ecco-jcc/jjw059
1. Marin-Jimenez I, Gobbo Montoya M, Panadero A, Canas M, Modino Y, Romero de Santos C, et al. Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project. Inflammatory bowel diseases. 2017;23(9):1492-8.
DOI: 10.1097/MIB.0000000000001205
2. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflammatory bowel diseases. 2011;17(2):590-8.
DOI: 10.1002/ibd.21363
3. Becker HM, Grigat D, Ghosh S, Kaplan GG, Dieleman L, Wine E, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian journal of gastroenterology & hepatology. 2015;29(2):77-84.
DOI: 10.1155/2015/815820
4. Catalan-Serra I, Huguet-Malaves JM, Minguez M, Torrella E, Paredes JM, Vazquez N, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterologia y hepatologia. 2015;38(6):355-63.
DOI: 10.1016/j.gastrohep.2014.09.003
5. Stjernman H, Tysk C, Almer S, Strom M, Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scandinavian journal of gastroenterology. 2010;45(6):696-706.
DOI: 10.3109/00365521003734141
6. Jelsness-Jorgensen LP, Moum B, Bernklev T. Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterology research and practice. 2011;2011:492034.
DOI: 10.1155/2011/492034
7. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal (Clinical research ed). 1986;292(6516):344.
DOI: 10.1136/bmj.292.6516.344
8. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003;25(4):277-83.
DOI: 10.1016/S0163-8343(03)00043-4
9. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995;7(9):853-8.
10. Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score. European journal of gastroenterology & hepatology. 2014;26(1):1-5.
DOI: 10.1097/MEG.0b013e328365d21a
11. Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflammatory bowel diseases. 2015;21(3):615-22.
DOI: 10.1097/MIB.0000000000000304
12. Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Journal of clinical gastroenterology. 1993;17(1):21-4.
DOI: 10.1097/00004836-199307000-00007
13. Eaden JA, Abrams K, Mayberry JF. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. The American journal of gastroenterology. 1999;94(12):3560-6.
DOI: 10.1111/j.1572-0241.1999.01536.x
14. Keegan D, McDermott E, Byrne K, Moloney D, Doherty GA, Mulcahy HE. Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2013;48(2):183-8.
DOI: 10.3109/00365521.2012.744090
15. Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2002;11(8):775-81.
DOI: 10.1023/A:1020841601110
16. Berroa de la Rosa E, Mora Cuadrado N, Fernandez Salazar L. The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(3):196-201.
DOI: 10.17235/reed.2017.4621/2016
17. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2004;96(3):174-84.
DOI: 10.4321/S1130-01082004000300003
18. Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, et al. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? PloS one. 2016;11(3):e0150620.
DOI: 10.1371/journal.pone.0150620
19. Wong S, Walker JR, Carr R, Graff LA, Clara I, Promislow S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012;26(8):525-31.
DOI: 10.1155/2012/735386
20. Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, et al. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2014;49(6):662-73.
DOI: 10.3109/00365521.2014.896408
21. de Castro ML, Sanroman L, Martin A, Figueira M, Martinez N, Hernandez V, et al. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(8):542-51.
22. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary pharmacology & therapeutics. 2012;36(1):57-63.
DOI: 10.1111/j.1365-2036.2012.05130.x
23. Berroa E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA. Are Worries and Concerns Information Side Effects? Inflammatory bowel diseases. 2015;21(9):E22.
DOI: 10.1097/MIB.0000000000000539
24. Panes J, de Lacy AM, Sans M, Soriano A, Pique JM. [Frequent Internet use among Catalan patients with inflammatory bowel disease]. Gastroenterologia y hepatologia. 2002;25(5):306-9.
25. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. European journal of gastroenterology & hepatology. 2009;21(9):1036-41.
DOI: 10.1097/MEG.0b013e328321b112
26. Nguyen DL, Rasheed S, Parekh NK. Patterns of Internet use by gastroenterologists in the management and education of patients with inflammatory bowel disease. Southern medical journal. 2014;107(5):320-3.
DOI: 10.1097/SMJ.0000000000000107
27. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, et al. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016;22(11):2678-87.
DOI: 10.1097/MIB.0000000000000951
28. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59(12):1652-61.
DOI: 10.1136/gut.2010.220160
29. Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's & colitis. 2016;10(9):1103-21.
DOI: 10.1093/ecco-jcc/jjw059
1. Marin-Jimenez I, Gobbo Montoya M, Panadero A, Canas M, Modino Y, Romero de Santos C, et al. Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients-The ENMENTE Project. Inflammatory bowel diseases. 2017;23(9):1492-8.
DOI: 10.1097/MIB.0000000000001205
2. Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflammatory bowel diseases. 2011;17(2):590-8.
DOI: 10.1002/ibd.21363
3. Becker HM, Grigat D, Ghosh S, Kaplan GG, Dieleman L, Wine E, et al. Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey. Canadian journal of gastroenterology & hepatology. 2015;29(2):77-84.
DOI: 10.1155/2015/815820
4. Catalan-Serra I, Huguet-Malaves JM, Minguez M, Torrella E, Paredes JM, Vazquez N, et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterologia y hepatologia. 2015;38(6):355-63.
DOI: 10.1016/j.gastrohep.2014.09.003
5. Stjernman H, Tysk C, Almer S, Strom M, Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scandinavian journal of gastroenterology. 2010;45(6):696-706.
DOI: 10.3109/00365521003734141
6. Jelsness-Jorgensen LP, Moum B, Bernklev T. Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year. Gastroenterology research and practice. 2011;2011:492034.
DOI: 10.1155/2011/492034
7. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal (Clinical research ed). 1986;292(6516):344.
DOI: 10.1136/bmj.292.6516.344
8. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General hospital psychiatry. 2003;25(4):277-83.
DOI: 10.1016/S0163-8343(03)00043-4
9. Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, et al. Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease. European journal of gastroenterology & hepatology. 1995;7(9):853-8.
10. Wardle RA, Mayberry JF. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score. European journal of gastroenterology & hepatology. 2014;26(1):1-5.
DOI: 10.1097/MEG.0b013e328365d21a
11. Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflammatory bowel diseases. 2015;21(3):615-22.
DOI: 10.1097/MIB.0000000000000304
12. Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Journal of clinical gastroenterology. 1993;17(1):21-4.
DOI: 10.1097/00004836-199307000-00007
13. Eaden JA, Abrams K, Mayberry JF. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease. The American journal of gastroenterology. 1999;94(12):3560-6.
DOI: 10.1111/j.1572-0241.1999.01536.x
14. Keegan D, McDermott E, Byrne K, Moloney D, Doherty GA, Mulcahy HE. Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2013;48(2):183-8.
DOI: 10.3109/00365521.2012.744090
15. Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2002;11(8):775-81.
DOI: 10.1023/A:1020841601110
16. Berroa de la Rosa E, Mora Cuadrado N, Fernandez Salazar L. The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(3):196-201.
DOI: 10.17235/reed.2017.4621/2016
17. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with inflammatory bowel disease on healthcare received. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2004;96(3):174-84.
DOI: 10.4321/S1130-01082004000300003
18. Pittet V, Vaucher C, Maillard MH, Girardin M, de Saussure P, Burnand B, et al. Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort? PloS one. 2016;11(3):e0150620.
DOI: 10.1371/journal.pone.0150620
19. Wong S, Walker JR, Carr R, Graff LA, Clara I, Promislow S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012;26(8):525-31.
DOI: 10.1155/2012/735386
20. Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, et al. Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scandinavian journal of gastroenterology. 2014;49(6):662-73.
DOI: 10.3109/00365521.2014.896408
21. de Castro ML, Sanroman L, Martin A, Figueira M, Martinez N, Hernandez V, et al. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2017;109(8):542-51.
22. Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients' knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow'). Alimentary pharmacology & therapeutics. 2012;36(1):57-63.
DOI: 10.1111/j.1365-2036.2012.05130.x
23. Berroa E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA. Are Worries and Concerns Information Side Effects? Inflammatory bowel diseases. 2015;21(9):E22.
DOI: 10.1097/MIB.0000000000000539
24. Panes J, de Lacy AM, Sans M, Soriano A, Pique JM. [Frequent Internet use among Catalan patients with inflammatory bowel disease]. Gastroenterologia y hepatologia. 2002;25(5):306-9.
25. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, et al. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. European journal of gastroenterology & hepatology. 2009;21(9):1036-41.
DOI: 10.1097/MEG.0b013e328321b112
26. Nguyen DL, Rasheed S, Parekh NK. Patterns of Internet use by gastroenterologists in the management and education of patients with inflammatory bowel disease. Southern medical journal. 2014;107(5):320-3.
DOI: 10.1097/SMJ.0000000000000107
27. Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, et al. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2016;22(11):2678-87.
DOI: 10.1097/MIB.0000000000000951
28. Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59(12):1652-61.
DOI: 10.1136/gut.2010.220160
29. Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's & colitis. 2016;10(9):1103-21.
DOI: 10.1093/ecco-jcc/jjw059
Related articles

Letter

Broadening perspectives in the treatment of chronic pouchitis

DOI: 10.17235/reed.2024.10865/2024

Letter

Intestinal ultrasound and its role in the acute setting: stenosing Crohn’s disease and acute bowel obstruction due to foreign body ingestion (dental post and crown)

DOI: 10.17235/reed.2024.10677/2024

Original

Ultrasound transmural healing correlates with higher adalimumab drug concentration in Crohn’s disease only in the short-term

DOI: 10.17235/reed.2024.10489/2024

Letter

Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) complicated with intestinal obstruction and perforation

DOI: 10.17235/reed.2024.10407/2024

Letter

A novel nomogram for predicting endoscopic remission in refractory Crohn’s disease with ustekinumab administration

DOI: 10.17235/reed.2024.10212/2023

Letter

Immuno-mediated colitis induced by nivolumab that mimics endoscopically and histologically an ulcerative colitis

DOI: 10.17235/reed.2024.10180/2023

Letter

An Epstein-Barr virus-positive mucocutaneous ulcer in a patient with ulcerative colitis: a recently described entity to take into account

DOI: 10.17235/reed.2024.10168/2023

Letter

Treatment with hyperbaric oxygen in a Crohn’s disease patient

DOI: 10.17235/reed.2024.10166/2023

Letter

Long-term remission achieved in a rare case of pyoderma gangrenosum and ulcerative colitis with surgery and postoperative infliximab

DOI: 10.17235/reed.2024.10144/2023

Letter

Lung abscess in a non-compliant patient with Crohn’s disease

DOI: 10.17235/reed.2024.10140/2023

Letter

Comments on: “Perianal Crohn’s disease: clinical implications, prognosis and use of resources”

DOI: 10.17235/reed.2023.10013/2023

Letter

Ulcerative colitis induced by obinutuzumab in a patient treated for a follicular lymphoma

DOI: 10.17235/reed.2023.10009/2023

Letter

Coincidental oral lesions in Crohn’s disease

DOI: 10.17235/reed.2023.9992/2023

Letter

Effectiveness of 4 L, 2 L, and 1 L polyethylene glycol (PEG) bowel preparation for colonoscopy in patients with ulcerative colitis: a retrospective study

DOI: 10.17235/reed.2023.9979/2023

Original

Psychological disorders and coping strategies in patients with inflammatory bowel disease. Their impact on health-related quality of life

DOI: 10.17235/reed.2023.9935/2023

Letter

Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study

DOI: 10.17235/reed.2023.9890/2023

Letter

Tofacitinib-induced eosinophilia

DOI: 10.17235/reed.2023.9831/2023

Original

Ulcerative colitis overall disease severity index predicts colectomy: a prospective cohort study

DOI: 10.17235/reed.2023.9754/2023

Letter

Infliximab-induced psoriasis in an ulcerative colitis patient successfully treated with guselkumab

DOI: 10.17235/reed.2023.9745/2023

Original

Development and validation of a nomogram to predict non-response to 5-aminosalicylic acid in patients with ulcerative colitis

DOI: 10.17235/reed.2023.9703/2023

Original

FiLaC® procedure for highly selected anal fistula patients: indications, safety and efficacy from an observational study at a tertiary referral center

DOI: 10.17235/reed.2023.9644/2023

Letter

Extensive involvement of indolent T-cell lymphoma in a patient with ulcerative colitis

DOI: 10.17235/reed.2023.9623/2023

Letter

Iatrogenic rectal perforation due to application of topical treatment in a patient with ulcerative colitis: a rare complication

DOI: 10.17235/reed.2023.9599/2023

Original

Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis

DOI: 10.17235/reed.2023.9537/2023

Letter

Severe outbreak of ulcerative colitis and cerebral neoplasia. Difficult management in COVID time

DOI: 10.17235/reed.2023.9527/2023

Letter

Duodenal stenosis surgical treatment in Crohn’s disease

DOI: 10.17235/reed.2023.9521/2023

Letter

Henoch-Schönlein purpura masquerading as Crohn’s disease flare

DOI: 10.17235/reed.2022.9414/2022

Original

Effectiveness and safety of ustekinumab dose escalation in Crohn’s disease: a multicenter observational study

DOI: 10.17235/reed.2023.9402/2022

Letter

Prediagnosis of soft tissue infection that was finally diagnosed as pyoderma gangrenosum of ulcerative colitis

DOI: 10.17235/reed.2022.9332/2022

Letter

Perianal Paget’s disease

DOI: 10.17235/reed.2022.9304/2022

Letter

Use of teduglutide for short bowel syndrome and Crohn’s disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy

DOI: 10.17235/reed.2022.9194/2022

Letter

A rare case of ulcerative colitis following Bacillus Calmette-Guérin therapy

DOI: 10.17235/reed.2022.9191/2022

Letter

Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome

DOI: 10.17235/reed.2022.9183/2022

Letter

Chinese dragon sign of ulcerative colitis

DOI: 10.17235/reed.2022.9154/2022

Letter

Pyoderma gangrenosum in ulcerative colitis - An exuberant and painful complication

DOI: 10.17235/reed.2022.9120/2022

Letter

Ulcerative colitis exacerbated by strongyloidiasis

DOI: 10.17235/reed.2022.9044/2022

Letter

A diagnostic challenge: chronic cutaneous ulcers as an isolated clinical finding in metastatic Crohn’s disease

DOI: 10.17235/reed.2022.8995/2022

Digestive Diseases Image

Intestinal and perianal tuberculosis: an uncommon clinical presentation and challenging diagnosis

DOI: 10.17235/reed.2022.8988/2022

Letter

Dual biologic therapy for severe ulcerative colitis, concomitant extraintestinal manifestations and an orbital osteoma: a successful treatment

DOI: 10.17235/reed.2022.8964/2022

Digestive Diseases Image

Peristomal cutaneous Crohn's disease by contiguity

DOI: 10.17235/reed.2022.8909/2022

Letter

A rare case of an intestinal ulcer: AIDS and amebic colitis in a homosexual man with ulcerative colitis

DOI: 10.17235/reed.2022.8903/2022

Letter

One appendix too many: a severe IBD-U case in remission after appendectomy

DOI: 10.17235/reed.2022.8809/2022

Original

Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak

DOI: 10.17235/reed.2022.8668/2022

Review

Clinical settings with tofacitinib in ulcerative colitis

DOI: 10.17235/reed.2022.8660/2022

Letter

Mesalazine induced interstitial pneumonitis in the COVID era

DOI: 10.17235/reed.2022.8635/2021

Original

Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia

DOI: 10.17235/reed.2022.8380/2021

Original

Evaluation of online content of proctological disorders in the Portuguese language

DOI: 10.17235/reed.2021.8333/2021

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Ileal endometriosis in a patient with Crohn’s disease: a diagnostic challenge

DOI: 10.17235/reed.2021.8187/2021

Review

Adherence improvement in patients with ulcerative colitis: a multidisciplinary consensus document

DOI: 10.17235/reed.2021.8130/2021

Original

Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area

DOI: 10.17235/reed.2021.8003/2021

Original

Perianal Crohn’s disease: clinical implications, prognosis and use of resources

DOI: 10.17235/reed.2021.7918/2021

Letter

Influence of the onset of the SARS-CoV-2 pandemic on the diagnosis and treatment of ulcerative colitis

DOI: 10.17235/reed.2021.7768/2020

Original

Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study

DOI: 10.17235/reed.2021.7683/2020

Original

Thiopurine adherence: a high prevalence with low impact on UC outcomes

DOI: 10.17235/reed.2021.7630/2020

Letter

A case of severe diverticulosis in a patient with ulcerative colitis

DOI: 10.17235/reed.2020.7529/2020

Review

The use of contrast-enhanced ultrasound for chronic inflammatory bowel disease

DOI: 10.17235/reed.2020.7499/2020

Original

Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results

DOI: 10.17235/reed.2020.7472/2020

Original

Prognostic value of ultrasound activity and parietal healing in patients with Crohn’s disease

DOI: 10.17235/reed.2020.7347/2020

Letter

Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn’s disease

DOI: 10.17235/reed.2020.7232/2020

Original

Preliminary experience of maintenance treatment with intravenous ustekinumab as a rescue treatment for loss of response to subcutaneous doses

DOI: 10.17235/reed.2020.7230/2020

Original

Ustekinumab treatment for toxic megacolon in severe colonic Crohn’s disease

DOI: 10.17235/reed.2020.7228/2020

Original

Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients

DOI: 10.17235/reed.2020.7202/2020

Letter

Author´s answer to: “Effect of adacolumn® in ulcerative colitis with COVID-19”

DOI: 10.17235/reed.2020.7188/2020

Original

Spanish online survey on informed consent for the performance of paracentesis. Do we have it? Do we use it?

DOI: 10.17235/reed.2020.7179/2020

Letter

The effect of Adacolumn® on ulcerative colitis with COVID-19

DOI: 10.17235/reed.2020.7156/2020

Original

Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn’s disease. A real life study

DOI: 10.17235/reed.2020.7124/2020

Review

Vitamin D and inflammatory bowel disease: what do we know so far?

DOI: 10.17235/reed.2020.7061/2020

Original

Glasgow prognostic score is a predictive index for postoperative infectious complications after total proctocolectomy in ulcerative colitis patients

DOI: 10.17235/reed.2020.7047/2020

Original

Prevalence and detection of undiagnosed active hepatitis C virus infections in Navarre, Spain, 2017-2019

DOI: 10.17235/reed.2020.7000/2020

Letter

Sweet syndrome in severe ulcerative flare

DOI: 10.17235/reed.2020.6995/2020

Review

The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn’s disease: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.6996/2020

Original

Normalization of long-term quality of life in Crohn’s disease patients receiving ustekinumab

DOI: 10.17235/reed.2020.6941/2020

Original

Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases

DOI: 10.17235/reed.2020.6938/2020

Original

National survey on the experiences of people with celiac disease in Spain. The CELIAC-SPAIN project

DOI: 10.17235/reed.2020.6929/2020

Letter

Retrograde enteroclysis by double balloon enteroscopy in a patient with blunt abdominal trauma: small bowel stricture, intraluminal vascular lesion and Crohn’s disease

DOI: 10.17235/reed.2020.6891/2020

Original

Treatment of abdominal fistulas in Crohn’s disease and monitoring with abdominal ultrasonography

DOI: 10.17235/reed.2020.6884/2020

Original

Is endoscopic treatment of small bowel strictures effective and safe in patients with Crohn’s disease?

DOI: 10.17235/reed.2020.6852/2019

Original

Meta-analysis of protein intake on the effect of Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2020.6851/2019

Original

Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn’s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain

DOI: 10.17235/reed.2020.6847/2019

Original

Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?

DOI: 10.17235/reed.2020.6832/2019

Letter

Vedolizumab-associated psoriasis: until where does gut selectivity go?

DOI: 10.17235/reed.2020.6817/2019

Original

Is the degree of i2a recurrence in Crohn’s disease secondary to ischemic phenomena?

DOI: 10.17235/reed.2020.6790/2019

Original

Predictive factors of clinical response to treatment with anti-TNF agents in ulcerative colitis: what have we learned from our patients?

DOI: 10.17235/reed.2020.6688/2019

Original

Association between autoimmune pancreatitis and ulcerative colitis: a report of 12 patients

DOI: 10.17235/reed.2020.6677/2019

Letter

Intra-abdominal desmoid tumor and chronic inflammatory bowel disease. An uncommon scenario

DOI: 10.17235/reed.2020.6648/2019

Letter

Crohn’s disease in patients treated with etanercept

DOI: 10.17235/reed.2019.6554/2019

Original

Diet as an environmental trigger in inflammatory bowel disease: a retrospective comparative study in two European cohorts

DOI: 10.17235/reed.2020.6552/2019

Original

Lewis score: a useful tool for diagnosis and prognosis in Crohn’s disease

DOI: 10.17235/reed.2020.6434/2019

Review

Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis

DOI: 10.17235/reed.2019.6336/2019

Original

Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease

DOI: 10.17235/reed.2019.6298/2019

Case Report

Regression of a giant pseudopolyp in a patient with colonic Crohn’s disease after therapy with infliximab

DOI: 10.17235/reed.2019.6252/2019

Original

The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China

DOI: 10.17235/reed.2019.6155/2019

Original

Differences in the need for adalimumab dose optimization between Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2019.6148/2018

Letter

A rare lymphoproliferative disorder associated with immunomodulating therapy in Crohn’s disease

DOI: 10.17235/reed.2019.5990/2018

Case Report

Leukocytoclastic vasculitis after vaccination in a patient with inflammatory bowel disease

DOI: 10.17235/reed.2019.5963/2018

Letter

The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?

DOI: 10.17235/reed.2019.5841/2018

Letter

Intravenous ustekinumab reinduction as a Crohn’s disease rescue strategy following a secondary non-response

DOI: 10.17235/reed.2019.5802/2018

Letter

Crohn’s disease and cystic fibrosis: there is still a lot to learn

DOI: 10.17235/reed.2018.5725/2018

Original

Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity

DOI: 10.17235/reed.2018.5714/2018

Original

Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn’s disease

DOI: 10.17235/reed.2018.5691/2018

Special Article

The current situation of digestive endoscopy units in the Valencian Community

DOI: 10.17235/reed.2019.5676/2018

Letter

Sweet syndrome after treatment with vedolizumab in a patient with Crohn’s disease

DOI: 10.17235/reed.2018.5603/2018

Original

The association between de novo inflammatory bowel disease and celiac disease

DOI: 10.17235/reed.2019.5535/2018

Editorial

Online social networks and inflammatory bowel disease

DOI: 10.17235/reed.2018.5496/2018

Original

Bile acid malabsorption in patients with chronic diarrhea and Crohn’s disease

DOI: 10.17235/reed.2018.5376/2017

Original

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months

DOI: 10.17235/reed.2018.5368/2017

Original

Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the “Gestiona hierro-EII” survey

DOI: 10.17235/reed.2018.5354/2017

Review

Intestinal tuberculosis and Crohn’s disease: the importance and difficulty of a differential diagnosis

DOI: 10.17235/reed.2018.5184/2017

Original

Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index

DOI: 10.17235/reed.2017.5137/2017

Original

Can we rely on inflammatory biomarkers for the diagnosis and monitoring Crohn’s disease activity?

DOI: 10.17235/reed.2017.5126/2017

Original

Enteral nutrition is associated with a decreased risk of surgical intervention in Crohn’s disease patients with spontaneous intra-abdominal abscess

DOI: 10.17235/reed.2017.5116/2017

Editorial

The complexity of evaluating and increasing adherence in inflammatory bowel disease

DOI: 10.17235/reed.2017.5143/2017

Original

Capsule endoscopy with PillCamSB2 versus PillCamSB3: has the improvement in technology resulted in a step forward?

DOI: 10.17235/reed.2017.5071/2017

Case Report

Serrated polyposis syndrome associated with long-standing inflammatory bowel disease

DOI: 10.17235/reed.2017.5068/2017

Case Report

Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis

DOI: 10.17235/reed.2017.5024/2017

Letter to the Editor

Fecal transplantation as a treatment for Clostridium difficile infection in patients with ulcerative colitis

DOI: 10.17235/reed.2017.4941/2017

Original

Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn’s disease

DOI: 10.17235/reed.2017.4931/2017

Original

Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis

DOI: 10.17235/reed.2017.4899/2017

Original

Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey

DOI: 10.17235/reed.2017.4748/2016

Letter to the Editor

Ulcerative colitis with gastric and duodenal involvement

DOI: 10.17235/reed.2017.4685/2016

Original

What is the real-life maintenance mesalazine dose in ulcerative colitis?

DOI: 10.17235/reed.2016.4620/2016

Original

The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire

DOI: 10.17235/reed.2017.4621/2016

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Original

Clinical status, quality of life, and work productivity in Crohn’s disease patients after one year of treatment with adalimumab

DOI: 10.17235/reed.2016.4600/2016

Original

The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis

DOI: 10.17235/reed.2016.4470/2016

Original

Management of the clinical issue of constipation with abdominal complaints in adults. A national survey of Primary Care physicians and gastroenterologists

DOI: 10.17235/reed.2016.4352/2016

Original

Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn’s disease

DOI: 10.17235/reed.2016.4318/2016

Letter to the Editor

Adnexal localization of Crohn’s disease and recurrent massive ovary cysts

DOI: 10.17235/reed.2016.4301/2016

Original

Meta-analysis of the association between appendiceal orifice inflammation and appendectomy and ulcerative colitis

DOI: 10.17235/reed.2016.4176/2015

Digestive Diseases Image

All that glitters is not gold. A different cause for an "ulcerative colitis"

Letter to the Editor

Ulcerative colitis in a patient with common variable immunodeficiency: does the treatment differ from the routine?

DOI: 10.17235/reed.2016.4115/2015

Original

Initial experience with golimumab in clinical practice for ulcerative colitis

DOI: 10.17235/reed.2016.4068/2015

Original

Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study

DOI: 10.17235/reed.2016.4066/2015

Original

Spanish multicenter study to estimate the incidence of chronic pancreatitis

DOI: 10.17235/reed.2016.4056/2015

Case Report

Mesalamine-induced myopericarditis - A case report

DOI: 10.17235/reed.2016.4016/2015

Original

Predictive factors of small bowel patency in Crohn's disease patients

DOI: 10.17235/reed.2015.3957/2015

Case Report

Metastatic Crohn’s disease in pediatrics

DOI: 10.17235/reed.2016.3948/2015

Editorial

INTENSIFICATION OF MAINTENANCE THERAPY WITH INFLIXIMAB IN ULCERATIVE COLITIS

DOI: 10.17235/reed.2015.3907/2015

Letter to the Editor

Crohn’s disease and Sweet’s syndrome: A debut together

DOI: 10.17235/reed.2015.3842/2015

Original

Impact of endoscopic monitoring in postoperative Crohn’s disease patients already receiving pharmacological prevention of recurrence

DOI: 10.17235/reed.2015.3836/2015

Original

FREQUENCY, PREDICTORS, AND CONSEQUENCES OF MAINTENANCE INFLIXIMAB THERAPY INTENSIFICATION IN ULCERATIVE COLITIS

DOI: 10.17235/reed.2015.3804/2015

Case Report

Primary liposarcoma of the sigmoid presenting as colonic intussusception - A case report

DOI: 10.17235/reed.2016.3943/2015

Original

THE MANAGEMENT OF LACTOSE INTOLERANCE AMONG PRIMARY CARE PHYSICIANS AND ITS CORRELATION WITH MANAGEMENT BY GASTROENTEROLOGISTS: THE SEPD-SEMG NATIONAL SURVEY

DOI: 10.17235/reed.2015.3771/2015

Case Report

Ovarian involvement in Crohn´s disease: A rare complication

DOI: 10.17235/reed.2015.3764/2015

Original

Impact of the age of diagnosis on the natural history of ulcerative colitis

DOI: 10.17235/reed.2015.3736/2015

Citation tools
Martín Fernández C, Maroto Martín C, Fernández Salazar L. Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information. 5331/2017


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1649 visits.
This article has been downloaded 196 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 23/10/2017

Accepted: 24/01/2018

Online First: 12/03/2018

Published: 27/04/2018

Article revision time: 54 days

Article Online First time: 140 days

Article editing time: 186 days


Share
This article has been rated by 3 readers.
Reader rating:
Valora este artículo:




Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
REED awards
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
REED awards
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
REED awards
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology